Now Closed

Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to interventional cardiology, endovascular medicine, or structural heart disease. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented or published elsewhere. Abstracts that are selected will be published in the Journal of the American College of Cardiology (JACC).

Note: Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.

Guidelines: Character limit is 2,200, including spaces (approximately 300-350 words).

Notification: Accepted presenters will be notified in mid-August.

Now Closed

Physicians and fellows from around the world, submit your most challenging coronary, endovascular, and structural heart disease cases. The best cases will be chosen by the course directors for presentation.

Guidelines: Character limit is 2,450 total for case summary, history, diagnostic tests, procedure, conclusion, comments. PowerPoint slide presentation highlighting your case is optional. Images: 10 MB. Video formats accepted: 30 MB mpeg, wmv, avi, mov, mpg, mp4.

Notification: Accepted presenters will be notified in September.

Now Closed

TCT Innovation Sessions

Submit your novel technologies relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease. Selected emerging technologies will be presented at TCT 2023.

TCT Shark Tank Innovation Competition

Enter the Shark Tank! The annual TCT meeting is the preeminent platform for concept-stage presentations of novel technologies in interventional cardiovascular medicine. Submit concept-stage novel technologies in interventional cardiovascular medicine for a chance to present to a panel of expert judges and compete for an award of $200,000 provided by the Jon DeHaan Foundation.

Your submission must be relevant to the monitoring, diagnosis, or treatment of coronary, endovascular, or structural heart disease and meet all three of the following criteria:

• Addresses an unmet clinical need
• Has preliminary patent application filed
• Includes preclinical or early human clinical data

Guidelines: Describe clinical indication for innovative device or technology. Character limit 2,450, including spaces. Submit 15-20 PowerPoint slides covering aspects of the technology.

Notification: Accepted presenters will be notified in mid-August.

Now Closed

Late-Breaking Clinical Trials and Science are typically:

• First-time presentations of first-in-human experiences with novel devices or drugs.
• Primary or important secondary endpoint results of prospective randomized clinical trials.
• Large-scale, impactful single-/multicenter registries.

If your submission is accepted, you will present it at TCT 2023. In addition, a few presentations will be chosen for the press conferences scheduled on the same day.

Embargo: The content of accepted late-breaking science is strictly embargoed until time of presentation.

Non-Qualifying Submissions: Please note that the following rarely qualify as late-breaking clinical trial submissions and instead, should be submitted as abstracts or to call for innovation: preclinical studies, early first-in-human device studies, and meta-analyses.

Guidelines: Total character limit is 3,250, including spaces (primary endpoints: 550-character limit; secondary endpoints: 550-character limit; funding sources: 500 character limit). Upload .png or .jpg files only.

Notification: Accepted presenters will be notified mid-September.

Now Closed

Younger than 40? Committed to academic and research excellence and have the accomplishments to demonstrate it? Apply for this Young Investigator Award!

The Linnemeier Award is designed to encourage young physicians in their pursuit of a life-long commitment to joint clinical and academic excellence. This award recognizes clinical and academic excellence in interventional cardiovascular medicine and aims to stimulate the continued commitment and dedication to both outstanding patient care and ongoing academic inquiry by young investigators.

The three finalists will become faculty at TCT 2023. The winner will be announced at the conference and will receive the award along with a $10,000 scholarship on the podium at TCT 2023.

Eligibility: We encourage both international and US-based applicants. Candidates for this award must be:

• Younger than 40 years old at the start of TCT 2023 (October 23, 2023), but excluding individuals who have attained the rank of associate or full professor.
• Specializing in interventional cardiovascular medicine (interventional cardiology, endovascular medicine, structural heart disease, pathology, etc.).

Guidelines: Required documents: CV, personal statement, clinical accomplishments, letters of recommendation, and supplemental information.